Haig P. Bozigian is Chief Development Officer at NEUROCRINE BIOSCIENCES INC (NBIX). They have made 35 open-market trades across 1 company since 2008, most recently 2021-02-08.
CIK 0001423837
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 35 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NBIX | 154,934 | $21.0M |
Shares reported on the most recent Form 4, priced at the 2021-02-09 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NBIX | SELL | 2021-02-05 | 2021-02-09 | $116.33 | $1.1M | -4.3% | -18.5% | -21.3% |
| NBIX | SELL | 2020-11-12 | 2020-11-16 | $90.74 | $410K | +3.1% | +6.5% | +21.3% |
| NBIX | SELL | 2020-08-05 | 2020-08-07 | $118.89 | $537K | -1.6% | -4.5% | -12.7% |
| NBIX | SELL | 2020-05-12 | 2020-05-14 | $114.94 | $14.2M | +7.3% | +3.9% | +2.9% |
| NBIX | SELL | 2020-04-24 | 2020-04-28 | $99.46 | $385K | +9.0% | +19.8% | +25.5% |
| NBIX | SELL | 2020-02-07 | 2020-02-11 | $103.33 | $335K | -9.5% | -24.4% | +6.0% |
| NBIX | SELL | 2020-02-05 | 2020-02-07 | $102.29 | $567K | -0.4% | -14.6% | +5.2% |
| NBIX | SELL | 2019-07-30 | 2019-07-31 | $92.46 | $5.8M | -2.2% | +2.6% | +1.0% |
| NBIX | SELL | 2019-07-15 | 2019-07-17 | $87.50 | $2.7M | -1.0% | +10.7% | +6.4% |
| NBIX | SELL | 2019-07-10 | 2019-07-12 | $87.63 | $1.3M | -0.2% | +9.8% | +2.6% |
| NBIX | SELL | 2019-06-18 | 2019-06-20 | $87.82 | $184K | -1.4% | +2.2% | +19.0% |
| NBIX | SELL | 2019-06-13 | 2019-06-17 | $82.62 | $2.9M | -4.8% | +1.8% | +13.0% |
| NBIX | SELL | 2019-06-03 | 2019-06-05 | $85.51 | $587K | +5.1% | +4.1% | +19.7% |
| NBIX | SELL | 2019-05-31 | 2019-06-03 | $85.02 | $3.3M | +1.4% | +3.5% | +18.2% |
| NBIX | SELL | 2019-05-24 | 2019-05-29 | $80.03 | $2.8M | +4.0% | +7.0% | +24.1% |
| NBIX | SELL | 2019-05-22 | 2019-05-23 | $80.03 | $104K | +3.9% | +7.3% | +24.9% |
| NBIX | SELL | 2019-05-16 | 2019-05-20 | $80.13 | $10.7M | +9.3% | +10.1% | +27.3% |
| NBIX | SELL | 2019-05-16 | 2019-05-20 | $80.13 | $5.3M | +9.3% | +10.1% | +27.3% |
| NBIX | SELL | 2019-05-13 | 2019-05-15 | $75.51 | $5.2M | +0.1% | +5.7% | +19.4% |
| NBIX | SELL | 2019-02-06 | 2019-02-08 | $83.54 | $154K | -8.8% | -5.6% | -7.0% |
| NBIX | SELL | 2019-02-04 | 2019-02-06 | $88.12 | $439K | -3.2% | -8.0% | -6.5% |
| NBIX | SELL | 2018-11-08 | 2018-11-13 | $110.00 | $4.0M | -7.0% | -26.3% | -14.5% |
| NBIX | SELL | 2018-11-06 | 2018-11-08 | $110.15 | $6.9M | -17.6% | -20.1% | -21.4% |
| NBIX | SELL | 2018-03-05 | 2018-03-07 | $90.00 | $6.8M | -7.0% | -16.0% | +8.9% |
| NBIX | SELL | 2018-02-05 | 2018-02-07 | $83.10 | $376K | +1.8% | +11.2% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.